https://biotechmorning.com/news/latus-bio-97m-low-dose-gene-therapy-huntingtons Biotech Morning en 2026-05-05T14:13:00.603Z The $97M Bet That Less Is More in Gene Therapy https://biotechmorning.com/news/cytokinetics-aficamten-data-challenges-camzyos Biotech Morning en 2026-05-05T14:12:18.628Z Cytokinetics Just Handed Bristol Myers Its Biggest Headache Yet https://biotechmorning.com/news/amgen-tepezza-monopoly-viridian-phase-3-win Biotech Morning en 2026-05-05T14:11:38.032Z Amgen's $2B Monopoly Just Got a Lot Less Comfortable https://biotechmorning.com/news/passage-bio-layoffs-fda-gene-therapy Biotech Morning en 2026-05-05T14:10:59.944Z Passage Bio Just Lost 75% of Its Team. The FDA Letter That Broke Them. https://biotechmorning.com/news/biotech-avengers-abia-trade-group-launch Biotech Morning en 2026-05-05T14:10:14.410Z Biotech's Avengers Just Assembled (But Can They Actually Fight?) https://biotechmorning.com/news/odyssey-therapeutics-ipo-filing-2026 Biotech Morning en 2026-05-05T14:09:33.575Z The $700M Startup That's Never Sold a Drug Just Filed to Go Public https://biotechmorning.com/news/celcuity-gedatolisib-breast-cancer-pik3ca-mutant-wild-type Biotech Morning en 2026-05-05T14:08:50.560Z The Breast Cancer Drug That Doesn't Care About Your Tumor's Genetics https://biotechmorning.com/news/trump-administration-psychedelics-fda-vouchers Biotech Morning en 2026-05-04T14:07:15.519Z The White House Just Went Pro-Psychedelics. Nobody Saw It Coming. https://biotechmorning.com/news/intellia-one-shot-crispr-gene-editing-hae Biotech Morning en 2026-05-04T14:06:36.003Z One Shot to Silence a Disease Forever https://biotechmorning.com/news/ucb-acquires-candid-therapeutics-2-billion Biotech Morning en 2026-05-04T14:05:53.213Z UCB Just Dropped $2 Billion on a Company That's Barely a Year Old https://biotechmorning.com/news/celcuity-gedatolisib-beats-novartis-piqray-breast-cancer Biotech Morning en 2026-05-04T14:05:12.040Z The $10 Million Drug That Just Humbled a Pharma Giant